Related Experiment Videos
Early captopril prevents myocardial infarction-induced hypertrophy but not angiogenesis
E A Kalkman1, P van Haren, P R Saxena
1Department of Pharmacology, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands.
Insights
Early captopril treatment after myocardial infarction (MI) prevents heart tissue growth without impacting blood vessel capacity. This improves blood flow and metabolism in infarcted hearts, aiding recovery.
Area of Science:
- Cardiology
- Pharmacology
- Physiology
Background:
- Myocardial infarction (MI) can lead to reactive hypertrophy.
- The impact of early captopril treatment on angiogenesis post-MI is not well understood.
- Captopril's effects on coronary flow and tissue mass require further investigation.
Purpose of the Study:
- To investigate the effects of early captopril administration on regional coronary flow relative to tissue mass.
- To assess captopril's influence on angiogenesis and reactive hypertrophy following myocardial infarction.
- To determine captopril's impact on cardiac metabolism post-MI.
Main Methods:
- Isolated perfused rat hearts subjected to coronary artery ligation.
- Early captopril administration (2 g/l drinking water) from day 1 to 3 weeks post-MI.
- Measurement of regional maximal vascular capacity using radioactive microspheres during nitroprusside-induced vasodilation.
- Assessment of lactate/purine ratio to indicate metabolic changes.
Main Results:
- Early captopril prevented reactive hypertrophy in infarcted heart regions, particularly the left ventricular free wall.
- Maximal vascular capacity remained unchanged by captopril treatment.
- Peak tissue perfusion improved due to the prevention of hypertrophy.
- Captopril normalized the elevated lactate/purine ratio in infarcted hearts, suggesting preserved aerobic metabolism.
Conclusions:
- Early captopril treatment effectively prevents post-MI hypertrophy without suppressing angiogenesis.
- This beneficial effect improves the vascularization to tissue mass ratio in the infarcted heart.
- Captopril likely preserves aerobic metabolism, contributing to improved cardiac function after myocardial infarction.
Abstract:
Delayed captopril, started after the healing phase of myocardial infarction, improves perfusion by reducing tissue weight without affecting the vascular capacity of the heart. Early captopril, during the healing phase, prevents reactive hypertrophy, but the effects on angiogenesis are unknown. Therefore, the effects of early captopril (2 g/l drinking water, from 1 day until 3 weeks after myocardial infarction) on regional coronary flow related to tissue mass, were studied in isolated perfused hearts from rats, subjected to coronary artery ligation. Regional maximal vascular capacity was measured during nitroprusside-induced vasodilation, using radioactive microspheres. Maximal vascular capacity was not changed by captopril. Reactive hypertrophy in infarcted hearts only reached statistical significance in the left ventricular free wall. Since captopril prevented hypertrophy but did not affect regional capacity, peak tissue perfusion was improved. Indicating effects on metabolism, captopril restored the increased lactate/purine ratio in infarcted hearts. Thus, early captopril treatment prevented post-myocardial infarction hypertrophy but did not suppress angiogenesis, thus beneficially influencing the vascularization/tissue mass ratio, probably reflected by preservation of aerobic metabolism.